Salge-Bartels Ursula, Huber Helga Marie, Kleiner Kornelia, Volkers Peter, Seitz Rainer, Heiden Margarethe
Division of Hematology/Transfusion Medicine, Paul Ehrlich Institute, Langen, Germany.
Transfus Med Hemother. 2009;36(5):317-324. doi: 10.1159/000232384. Epub 2009 Aug 21.
BACKGROUND: Umbilical cord blood (CB) is widely used for hematopoietic stem cell transplantation and holds promise for the development of innovative medicinal products. In order to find out whether the conditions for collection and storage before processing might have an impact on the quality of CB preparations, viability and the clonogenic potential were assessed. METHODS: CB was collected under field conditions. Flow cytometry was used to determine leukocytes, CD34/CD45+ cells, viability, and nucleated red blood cells (NRBC). Clonogenic activity was determined using isolated mononuclear cells (MNC). RESULTS: Neither plasma citrate concentrations nor storage temperature (within 24 h) affected cell viability or colony formation. After storage for 49-80 h, leukocyte viability declined by about 16% compared to CB stored up to 24 h. In contrast, the clonogenic activity and CD34/CD45+ cell content were not affected. A higher gestational age was associated with a lower yield of clonogenic activity compared to midterm deliveries. NRBC varied widely (median 7.3%; range 0.63-17.3%) without relation to gestational age or colony formation. There was a close correlation between the percentage of viable CD34/CD45+ cells and colony formation (r = 0.77 for CFU-GM; r = 0.75 for CFU-C). CONCLUSIONS: The content of viable CD34/CD45+ cells represents the clonogenic activity of CB preparations. Therefore, determination of viable CD34/CD45+ cells should be generally performed as a routine quality control assay.
背景:脐带血(CB)被广泛用于造血干细胞移植,并有望开发创新型医药产品。为了弄清楚处理前的采集和储存条件是否会对CB制剂的质量产生影响,对其活力和克隆形成潜力进行了评估。方法:在现场条件下采集CB。采用流式细胞术测定白细胞、CD34/CD45+细胞、活力和有核红细胞(NRBC)。使用分离的单核细胞(MNC)测定克隆形成活性。结果:血浆柠檬酸盐浓度和储存温度(24小时内)均未影响细胞活力或集落形成。储存49 - 80小时后,与储存长达24小时的CB相比,白细胞活力下降了约16%。相比之下,克隆形成活性和CD34/CD45+细胞含量未受影响。与中期分娩相比,较高的胎龄与较低的克隆形成活性产量相关。NRBC差异很大(中位数7.3%;范围0.63 - 17.3%),与胎龄或集落形成无关。存活的CD34/CD45+细胞百分比与集落形成之间存在密切相关性(CFU - GM的r = 0.77;CFU - C的r = 0.75)。结论:存活的CD34/CD45+细胞含量代表了CB制剂的克隆形成活性。因此,一般应将测定存活的CD34/CD45+细胞作为常规质量控制检测方法。